Scenarios to manage the hepatitis C disease burden and associated economic impact of treatment in Turkey

---

Copy For Citation

ÖRMECİ N., Malhan S., Balik I., ERGÖR G., Razavi H., Robbins S.

HEPATOLOGY INTERNATIONAL, vol.11, no.6, pp.509-516, 2017 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 11 Issue: 6
• Publication Date: 2017
• Doi Number: 10.1007/s12072-017-9820-3
• Journal Name: HEPATOLOGY INTERNATIONAL
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.509-516
• Keywords: HCV, Economic impact, Cost-effectiveness, Treatment, WHO Targets, GENOTYPE 1 INFECTION, UNITED-STATES, LIVER-DISEASE, RISK-FACTORS, HCV, SOFOSBUVIR, LEDIPASVIR, VIRUS, RIBAVIRIN, ABT-450/R-OMBITASVIR
• Dokuz Eylül University Affiliated: Yes

Abstract

Hepatitis C virus (HCV) infection is a significant health problem. The aim of this study is to evaluate the cost-effectiveness of HCV treatment and estimate its economic burden in Turkey.